Morepen Laboratories Ltd (MORL)

25.10 +0.15 (+0.60%)
Close INR Disclaimer

Morepen Laboratories Ltd Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
1607
Equity Type
ORD
Morepen Laboratories Limited is a pharmaceutical company. The Company is engaged in the business of manufacturing, producing, developing, and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also the home health products. Its APIs include Apixaban, Edoxaban, Sitagliptin, Linagliptin, Empagliflozin, Atorvastatin, Loratadine, Desloratadine, Montelukast Sodium, Atorvastatin Calcium, Fexofenadine, Sitagliptin Phosphate, Vildagliptin and Rivaroxaban, among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.
Contact Information
Address
Udyog Vihar-III, Sector 20 Gurugram,122016 India
Phone
91 12 4489 2000
Fax
-
Top Executives
Name
Age
Since
Title
Manoj Joshi 65 1992 Independent Non Executive Director
Bhupender Raj Wadhwa 57 2005 Independent Non Executive Director
Sukhcharan Singh 80 2005 Independent Non Executive Director
Praveen Kumar Dutt 54 2019 Independent Director
- Savita 38 2020 Independent Director
Sushil Suri 58 1992 Chairman & MD
Sanjay Suri 54 2015 Whole-Time Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles